Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 10/19/15

Massimo Cardinali, M.D.

Massimo Cardinali

Senior Regulatory Affairs Manager

Massimo Cardinali, M.D. joined the Drug Regulatory Group in the Regulatory Affairs Branch in 2014. Dr. Cardinali graduated from the Medical School of the University of Pisa, Italy, in 1984. In 1986, after completing his residency in the Nuclear Medicine Department of the University of Pisa, he moved to NIH to conduct basic research in Oncology. Dr. Cardinali has nearly 20 years of experience in clinical research having worked as a Medical Officer in the Oncology Branch at CBER, FDA, and in the Vaccine Research Branch at the Division of AIDS (DAIDS), NIAID, NIH. Prior to coming to NCI, Dr. Cardinali also served as a Senior Regulatory Manager in the Regulatory Affairs Branch at DAIDS. Dr. Cardinali provides regulatory support and IND management for a portfolio of NCI-sponsored clinical protocols; provides regulatory advice for other members of CTEP; and facilitates communications with the FDA.

About the Branch Chief

Bhanu Ramineni, M.S., M.S. Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology. More…